Sahu M, Praharaj D, Bhadoria A
J Clin Exp Hepatol. 2024; 15(2):102421.
PMID: 39588050
PMC: 11585777.
DOI: 10.1016/j.jceh.2024.102421.
Abavisani M, Ansari B, Ebadpour N, Sahebkar A
Clin Exp Vaccine Res. 2024; 13(4):271-300.
PMID: 39525670
PMC: 11543789.
DOI: 10.7774/cevr.2024.13.4.271.
Elzouki A, Elshafei M, Aziz A, Elzouki I, Waheed M, Farooqui K
Qatar Med J. 2023; 2023(3):21.
PMID: 38089670
PMC: 10714019.
DOI: 10.5339/qmj.2023.21.
Tan E, Lim W, Thong E, Chavatte J, Zhang J, Lim J
Transplant Direct. 2023; 9(10):e1537.
PMID: 37745946
PMC: 10513132.
DOI: 10.1097/TXD.0000000000001537.
Lautem A, Boedecker-Lips S, Schneider E, Runkel S, Feist C, Lang H
Pathogens. 2023; 12(7).
PMID: 37513757
PMC: 10383075.
DOI: 10.3390/pathogens12070910.
Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave.
Herting A, Jahnke-Triankowski J, Harberts A, Schaub G, Lutgehetmann M, Ruether D
Viruses. 2023; 15(2).
PMID: 36851510
PMC: 9958724.
DOI: 10.3390/v15020297.
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients.
Luxenburger H, Reeg D, Lang-Meli J, Reinscheid M, Eisner M, Bettinger D
J Hepatol. 2023; 78(5):1017-1027.
PMID: 36804404
PMC: 10019593.
DOI: 10.1016/j.jhep.2023.02.007.
SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort.
Zhu X, Lu Y, Xue F, Luo Y, Feng M, Qiu B
Virol J. 2023; 20(1):28.
PMID: 36774503
PMC: 9918817.
DOI: 10.1186/s12985-023-01978-4.
Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
Busa R, Russelli G, Miele M, Sorrentino M, Di Bella M, Timoneri F
Viruses. 2022; 14(10).
PMID: 36298854
PMC: 9611839.
DOI: 10.3390/v14102299.
Liver transplantation during COVID-19: Adaptive measures with future significance.
Gyftopoulos A, Ziogas I, Montenovo M
World J Transplant. 2022; 12(9):288-298.
PMID: 36187879
PMC: 9516488.
DOI: 10.5500/wjt.v12.i9.288.
Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection.
Miele M, Busa R, Russelli G, Sorrentino M, Di Bella M, Timoneri F
Microorganisms. 2022; 10(8).
PMID: 36013981
PMC: 9415050.
DOI: 10.3390/microorganisms10081563.
Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents.
Kamei K, Ogura M, Sato M, Nishi K, Shoji K, Funaki T
Pediatr Nephrol. 2022; 38(4):1099-1106.
PMID: 35913562
PMC: 9340689.
DOI: 10.1007/s00467-022-05633-y.
Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.
Burra P, Russo F
Liver Int. 2022; 42(6):1225-1228.
PMID: 35678039
PMC: 9347769.
DOI: 10.1111/liv.15226.
Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients.
Furian L, Russo F, Zaza G, Burra P, Hartzell S, Bizzaro D
Front Immunol. 2022; 13:853682.
PMID: 35493446
PMC: 9047689.
DOI: 10.3389/fimmu.2022.853682.
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
Manothummetha K, Chuleerarux N, Sanguankeo A, Kates O, Hirankarn N, Thongkam A
JAMA Netw Open. 2022; 5(4):e226822.
PMID: 35412626
PMC: 9006106.
DOI: 10.1001/jamanetworkopen.2022.6822.
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
Kwon J, Tenforde M, Gaglani M, Talbot H, Ginde A, McNeal T
J Infect Dis. 2022; 226(5):797-807.
PMID: 35385875
PMC: 9047160.
DOI: 10.1093/infdis/jiac118.
Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.
Meunier L, Sanavio M, Dumortier J, Meszaros M, Faure S, Bedoya J
Liver Int. 2022; 42(8):1872-1878.
PMID: 35338550
PMC: 9115190.
DOI: 10.1111/liv.15258.
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
Toniutto P, Falleti E, Cmet S, Cussigh A, Veneto L, Bitetto D
J Hepatol. 2022; 77(1):152-162.
PMID: 35283215
PMC: 8908852.
DOI: 10.1016/j.jhep.2022.02.015.
SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses.
Grupper A, Katchman H
Curr Transplant Rep. 2022; 9(1):35-47.
PMID: 35096509
PMC: 8783189.
DOI: 10.1007/s40472-022-00359-0.
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.
Galmiche S, Luong Nguyen L, Tartour E, de Lamballerie X, Wittkop L, Loubet P
Clin Microbiol Infect. 2022; 28(2):163-177.
PMID: 35020589
PMC: 8595936.
DOI: 10.1016/j.cmi.2021.09.036.
